The transcription factor NF-κB initiates gene expression in response to a variety of cell stimuli and is essential for animal life, although its over-expression and deregulation is closely linked to cancer development. In non-dividing cells it is "off" and associated with inhibitory proteins; it is activated by the degradation of these. The first step in initiating degradation is phosphorylation of the inhibitory proteins by a protein complex termed the IKK complex, or signalosome. Some viruses contain proteins known as vFLIPs that interact with, and activate, the signalosome, thus triggering the degradation of the inhibitory proteins, the activation of NK-κB, and cell division. Tracey Barrett of the School of Crystallography, Birkbeck College, London, and a core member of the Institute of Structural and Molecular Biology, and her colleagues have now solved the X-ray crystal structure of vFLIP from the Kaposi's sarcoma herpes virus (KSHV) bound to its host target IKKγ, shedding light on the mechanisms through which this viral protein activates the signalosome.
Kaposi's sarcoma herpes virus or human herpesvirus 8 is best known as the causative agent of Kaposi's sarcoma [2] , a skin cancer which is rare in people with intact immune systems but is commonly associated with HIV infection and is one of the infectious diseases that the World Health Organisation defines as indicative of full-blown AIDS 1 . This virus, and others that similarly cause proliferative diseases, hijacks the signalling pathways that control division in normal cells through activation of NF-kB. The clumsily named viral Fas-associated death domain interleukin-1β-converting enzyme inhibitor protein (ksvFLIP) is homologous to, and has a similar function to, proteins in animal cells that turn this pathway on through interactions with the IKK complex, or signalosome: with the crucial difference that vFLIP is present in, and sends proliferative signals to, all infected cells.
The signalosome is a dynamic, multi-protein assembly in which one subunit, known as IKKγ, regulates the first kinase to be activated, IKKβ. IKKγ may therefore be thought of as a "molecular switch"; it has been associated with many other proteins including DNA repair proteins and phosphatases, and mutations that reduce its activity have been implicated in a range of genetic disorders. Previous studies have indicated that ks-vFLIP interacts directly with IKKγ [3, 4] but, although the structure of a homologous vFLIP protein from a pox virus is available [5] , no Barrett and her co-workers therefore set out to solve the structure of ks-vFLIP bound to a fragment of IKKγ. Although several complexes formed crystals, only one gave reproducible X-ray diffraction: a complex of a C-terminally truncated form of ks-vFLIP with a fragment of about 120 amino acids from the centre of IKKγ. Most of the ks-vFLIP sequence is formed from two copies of the death effector or DED domain (Figure 1a) , and the construct crystallised contained the whole of both these domains. IKKγ has a complex domain structure (Figure 1b) with the fragment crystallised, between residues 150 and 272, consisting of parts of two coiled-coil domains spanning an alpha-helical domain. The structure of the complex, solved to 3.2 Å resolution, forms a dimer with the two extended IKKγ fragments in the centre. It can be said to resemble an insect head, with the two vFLIP monomers representing the eyes and the IKKγ molecules the antennae ( Figure  1c) . In spite of the absence of canonical coiled-coil motifs from the centre of the IKKγ fragment crystallised, these molecules pack together to form a parallel, intermolecular coiled coil. This is consistent with the theory that IKKγ undergoes a significant conformational change on activation, from a compact to an extended form [6] . hydrophobic. Site directed mutagenesis of three residues in cleft1 confirmed the importance of this cleft in binding IKKγ; the most disruptive mutations were to Ala57, which lines the upper pocket and binds a large phenylalanine residue; increasing the size of this residue will block the pocket, preventing this residue from binding. Mutations in IKKγ can cause a serious genetic disorder, ectodermal dysplasia with immunodeficiency (EDA-ID) which is characterised by recurrent, severe and often life-threatening infections resulting from defective signalosome-mediated NF-κB activation [7] . Point mutations associated with this disease have been found throughout the molecule; one of these, L227P, lies within the fragment of IKKγ observed in this structure.
When this mutation was introduced into the complex, the resulting construct was disordered, susceptible to proteolysis and could not be purified. This result, consistent with the expected consequence of introducing a proline into a largely alpha-helical protein region, illustrates that this mutated IKKγ is unlikely to form part of a stable signalosome.
It is clear that the fragment of IKKγ that is stable in an extended conformation when bound to the hydrophobic cleft of vFLIP will not be stable in a similar conformation in solution. Several groups have suggested that the inactive solution conformation of this molecule will be a helical bundle, with key residues buried and so inaccessible to protein-protein interactions ( [6] ; Figure 3a ). Barrett and co-workers propose that IKKγ unfolds into its active form only when stimulated by the presence of a cellular or viral FLIP protein (Figure 3b) , and that other elements of the complex are only then recruited to form the active signalosome. Designing molecules that disrupt vFLIP-IKKγ complex formation, and thus constitutive activation of the IKK complex, may present a novel therapeutic strategy against Kaposi's sarcoma and some other virally associated forms of cancer.
